Every story in this section, newest first — page 269 of 373.
CalciMedica (NASDAQ:CALC) reported its full-year 2025 financial results on Tuesday, outlining a path forward for its lead candidate, Auxora™, despite the recent discontinuation of its primary kidney injury study.
SOPHiA GENETICS (NASDAQ:SOPH) reported a strong finish to its fiscal year on Tuesday, pairing double-digit revenue growth with significant margin expansion as the healthcare-tech firm moves closer to its goal of operational profitability.
Scholar Rock (NASDAQ:SRRK) reported a significant increase in annual spending on Tuesday, reflecting the heavy operational costs of transitioning from a purely clinical-stage firm to a commercial-ready biopharmaceutical entity.
Versant Media Group (NASDAQ:VSNT) marked its first full year as an independent company by initiating an aggressive capital return program, signaling confidence in its cash-generation even as it navigates a transition away from former parent Comcast.
Viking Holdings (NYSE:VIK) reported a surge in full-year profitability on Tuesday, bolstered by an aggressive fleet expansion and a luxury travel boom that has already filled the vast majority of its 2026 sailing schedule.
Best Buy (NYSE:BBY) reported fourth-quarter earnings that cleared Wall Street’s profitability hurdles on Tuesday, though a slight revenue miss highlighted the continued caution of consumers regarding big-ticket electronics.
AutoZone (NYSE:AZO) reported an 8.1% increase in second-quarter sales on Tuesday, as the company’s aggressive store expansion and inflation-driven pricing offset a dip in net income caused by technical accounting charges.
Kontoor Brands (NYSE:KTB) posted a sharp increase in fourth-quarter revenue on Tuesday, clearing the $1 billion threshold as the company reaps the benefits of its 2025 acquisition of Helly Hansen and continued momentum in its core denim business.
Sea Limited (NYSE:SE) capped a transformative fiscal year with a massive jump in bottom-line growth, signaling that the Southeast Asian internet giant has successfully pivoted from cash-burning expansion to a sustainable, high-margin model.
Target (NYSE:TGT) posted a solid fourth-quarter performance on Tuesday, as the big-box retailer leaned into its digital marketplace and subscription services to offset a broader slowdown in discretionary consumer spending.
Civeo (NYSE:CVEO) reported a significant improvement in its quarterly bottom line and a jump in cash flow, as aggressive cost-reduction efforts in Canada and a strategic expansion in Australia began to pay off.
Thor Industries (NYSE:THO) reported a return to profitability in its fiscal second quarter, bolstered by strong motorized RV demand, while simultaneously moving to dismantle its long-standing decentralized business model in North America.
Hycroft Mining Holding (NASDAQ:HYMC) revealed a substantial expansion of its precious metals deposit on Tuesday, coupled with a strengthened liquidity position that places the developer among the few debt-free juniors in the sector.
Esperion Therapeutics (NASDAQ:ESPR) moved to significantly broaden its cardiovascular portfolio on Tuesday, announcing a deal to acquire privately held Corstasis Therapeutics and its first-of-its-kind nasal spray for heart failure-related edema.
Flowco Holdings completed its acquisition of Valiant Artificial Lift Solutions on Tuesday, a $200 million move that significantly broadens its technology portfolio in the high-stakes Permian Basin.
Greenwich LifeSciences (NASDAQ:GLSI) surged ahead in its clinical timeline on Tuesday, reporting a significant acceleration in patient recruitment for its pivotal Phase III breast cancer study.
Lithia & Driveway (NYSE:LAD) continued its aggressive expansion into high-growth U.S. markets on Tuesday, announcing the acquisition of two dealerships that bolster its presence in both the luxury and volume segments.
On Holding reported a double-digit jump in fourth-quarter sales, fueled by an explosive performance in Asia-Pacific and record-high gross margins, even as a decline in net income underscored the costs of its rapid global scaling.
WeRide (NASDAQ:WRD), the Guangzhou-based autonomous driving unicorn, has officially halted its robotaxi fleet in Dubai.
Amazon Web Services (AWS) disclosed on Tuesday that drone strikes directly hit two of its facilities in the United Arab Emirates.
Precision BioSciences (NASDAQ:DTIL) announced Monday that it has achieved a $7.5 million clinical milestone under its licensing agreement with TG Therapeutics (NASDAQ:TGTX).
GT Biopharma (NASDAQ:GTBP) reported fiscal 2025 results on Monday, detailing a significant pivot toward its advanced camelid nanobody platform.
Astrana Health (NASDAQ:ASTH) delivered a year of explosive scale in 2025, according to financial results released Monday, with total revenue reaching $3.18 billion.
AAON (NASDAQ:AAON) reported fourth-quarter net income of $32 million on Monday, falling short of Wall Street expectations as the company absorbed significant costs related to its rapid capacity expansion.
